Leaflet CEXIDAL 3mg/0.25mg/ml 3mg / ml / 25mg / ml ear drops solution


Indicated for: ear infections

Substance: ciprofloxacin + fluocinolone (fluoroquinolone antibiotic + glucocorticoid)

ATC: S02CA05 (Sensory organs | Corticosteroids and antiinfectives in combination)

The combination of ciprofloxacin and fluocinolone is used in the treatment of external ear infections, such as acute otitis externa. Ciprofloxacin is an antibiotic that acts against bacteria, while fluocinolone is a corticosteroid that reduces inflammation and pain.

The medication is administered as ear drops, as directed by a doctor, usually twice daily. It is important for patients to follow the usage instructions to ensure the effectiveness of the treatment.

Patients should be aware of potential side effects, such as local irritation, a burning sensation, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local irritation and a burning sensation. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before use.

General data about CEXIDAL 3mg/0.25mg/ml 3mg / ml / 25mg / ml

  • Substance: ciprofloxacin + fluocinolone
  • Date of last drug list: 01-06-2023
  • Commercial code: W59184001
  • Concentration: 3mg / ml / 25mg / ml
  • Pharmaceutical form: ear drops solution
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABORATORIOS SALVAT, S.A. - SPANIA
  • Holder: LABORATORIOS SALVAT, S.A. - SPANIA
  • Number: 9556/2016/01
  • Shelf life: 2 years-after packing for marketing; after the first opening-1 luna

Pharmaceutical forms available for ciprofloxacin + fluocinolone

Concentrations available for ciprofloxacin + fluocinolone

  • 3mg/0.25mg/ml
  • 3mg/0.5mg/ml
  • 3mg/ml/25mg/ml